Zacks Research Has Negative Outlook of Delek US Q1 Earnings

Delek US Holdings, Inc. (NYSE:DK - Free Report) - Analysts at Zacks Research cut their Q1 2026 earnings per share estimates for shares of Delek US in a note issued to investors on Wednesday, June 18th. Zacks Research analyst R. Department now forecasts that the oil and gas company will post earnings of ($1.22) per share for the quarter, down from their previous estimate of ($0.90). The consensus estimate for Delek US's current full-year earnings is ($5.50) per share. Zacks Research also issued estimates for Delek US's Q2 2026 earnings at ($0.10) EPS, Q3 2026 earnings at ($0.40) EPS, Q4 2026 earnings at ($0.63) EPS, FY2026 earnings at ($2.35) EPS, Q1 2027 earnings at ($0.06) EPS and FY2027 earnings at ($1.09) EPS.

Delek US (NYSE:DK - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The oil and gas company reported ($2.32) earnings per share for the quarter, missing the consensus estimate of ($2.27) by ($0.05). The business had revenue of $2.64 billion during the quarter, compared to analyst estimates of $2.56 billion. Delek US had a negative net margin of 6.10% and a negative return on equity of 63.88%. The company's revenue was down 18.1% on a year-over-year basis. During the same quarter last year, the firm posted ($0.41) earnings per share.

DK has been the subject of several other reports. Wells Fargo & Company boosted their price target on Delek US from $11.00 to $15.00 and gave the company an "underweight" rating in a report on Wednesday, June 11th. Scotiabank reduced their target price on Delek US from $24.00 to $14.00 and set a "sector perform" rating on the stock in a report on Friday, April 11th. Raymond James Financial reduced their target price on Delek US from $24.00 to $23.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. UBS Group reduced their target price on Delek US from $21.00 to $13.25 and set a "neutral" rating on the stock in a report on Wednesday, April 9th. Finally, Piper Sandler reduced their target price on Delek US from $18.00 to $17.00 and set a "neutral" rating on the stock in a report on Friday, March 7th. Five research analysts have rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $17.60.

Delek US Trading Up 1.5%

DK traded up $0.31 during trading on Monday, hitting $21.10. The company's stock had a trading volume of 952,943 shares, compared to its average volume of 1,363,766. The firm's 50 day moving average price is $17.56 and its 200-day moving average price is $17.00. The company has a debt-to-equity ratio of 7.05, a current ratio of 0.85 and a quick ratio of 0.53. The stock has a market cap of $1.28 billion, a PE ratio of -1.90 and a beta of 0.96. Delek US has a twelve month low of $11.03 and a twelve month high of $25.68.

Delek US Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, May 19th. Investors of record on Monday, May 12th were issued a $0.255 dividend. The ex-dividend date was Monday, May 12th. This represents a $1.02 annualized dividend and a yield of 4.83%. Delek US's dividend payout ratio is currently -9.18%.

Institutional Trading of Delek US

Several large investors have recently added to or reduced their stakes in the stock. Kawa Capital Management Inc increased its holdings in Delek US by 72.2% in the 1st quarter. Kawa Capital Management Inc now owns 400,000 shares of the oil and gas company's stock valued at $6,192,000 after purchasing an additional 167,750 shares in the last quarter. Rhumbline Advisers increased its holdings in Delek US by 3.4% in the 1st quarter. Rhumbline Advisers now owns 121,201 shares of the oil and gas company's stock valued at $1,826,000 after purchasing an additional 4,031 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Delek US by 7.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,871 shares of the oil and gas company's stock valued at $2,213,000 after purchasing an additional 9,827 shares in the last quarter. Yaupon Capital Management LP acquired a new stake in Delek US in the 1st quarter valued at $3,095,000. Finally, Empowered Funds LLC grew its stake in shares of Delek US by 1.8% during the first quarter. Empowered Funds LLC now owns 341,913 shares of the oil and gas company's stock valued at $5,153,000 after acquiring an additional 5,981 shares in the last quarter. 97.01% of the stock is currently owned by institutional investors and hedge funds.

About Delek US

Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.